• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆管腺瘤可能是小胆管型肝内胆管癌的前驱病变。

Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma.

机构信息

Department of Human Pathology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.

Division of Pathology, Fukui Saiseikai Hospital, Fukui, Japan.

出版信息

Histopathology. 2021 Jan;78(2):310-320. doi: 10.1111/his.14222. Epub 2020 Sep 15.

DOI:10.1111/his.14222
PMID:33405289
Abstract

BACKGROUND/AIMS: Precursor lesions of small duct type intrahepatic cholangiocarcinoma (small duct iCCA) have not been clarified so far. We hypothesised that precursor lesions may be frequently distributed in the background liver of small duct iCCA.

METHODS AND RESULTS

We determined by histology the presence of bile duct adenomas and von Meyenburg complexes as candidate precursor lesions in the background liver of small duct iCCA, with other primary liver carcinomas as control. Subjects included 28 patients with small duct iCCA, 29 with large duct iCCAs, 60 with combined hepatocellular-cholangiocarcinoma (Comb) and 40 with hepatocellular carcinoma (HCC). The prevalence of bile duct adenomas in the background liver was significantly higher in small duct iCCA (35.7%) compared to other primary liver carcinomas (Comb, 4.9%; 10%, HCC) (P < 0.01). The prevalence of bile duct adenomas was significantly associated with the presence of von Meyenburg complexes and ductal plate malformation-like patterns in small duct iCCAs and Combs. Von Meyenburg complexes were detected in 11 small duct iCCA (39.3%), five large duct iCCAs (17.2%), 10 Comb (16.4%) and 13 HCC (33.3%), respectively (P > 0.05). Small duct iCCAs showed altered expression of ARID1A (46.4%), p53 (39.3%), PBRM1 (14.3%), IMP3 (85.7%) and EZH2 (82.1%), whereas these markers were negative in bile duct adenomas.

CONCLUSION

Bile duct adenomas may be precursor lesions of small duct iCCAs. Alteration of ARID1A, p53 or PBRM1 may be involved in the carcinogenesis of small duct iCCAs.

摘要

背景/目的:小胆管型肝内胆管癌(小胆管 iCCA)的癌前病变尚未阐明。我们假设癌前病变可能在小胆管 iCCA 的背景肝中频繁分布。

方法和结果

我们通过组织学确定了胆管腺瘤和迈耶伯格复合体作为小胆管 iCCA 背景肝中候选癌前病变的存在,以其他原发性肝癌为对照。研究对象包括 28 例小胆管 iCCA 患者、29 例大胆管 iCCA 患者、60 例肝细胞癌-胆管细胞癌(Comb)患者和 40 例肝细胞癌(HCC)患者。小胆管 iCCA 背景肝中胆管腺瘤的患病率明显高于其他原发性肝癌(Comb,4.9%;10%,HCC)(P<0.01)。胆管腺瘤的患病率与小胆管 iCCA 和 Comb 中迈耶伯格复合体和导管板畸形样模式的存在显著相关。11 例小胆管 iCCA(39.3%)、5 例大胆管 iCCA(17.2%)、10 例 Comb(16.4%)和 13 例 HCC(33.3%)分别检测到迈耶伯格复合体(P>0.05)。小胆管 iCCA 显示 ARID1A(46.4%)、p53(39.3%)、PBRM1(14.3%)、IMP3(85.7%)和 EZH2(82.1%)的表达改变,而胆管腺瘤则呈阴性。

结论

胆管腺瘤可能是小胆管 iCCA 的癌前病变。ARID1A、p53 或 PBRM1 的改变可能参与小胆管 iCCA 的癌变。

相似文献

1
Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma.胆管腺瘤可能是小胆管型肝内胆管癌的前驱病变。
Histopathology. 2021 Jan;78(2):310-320. doi: 10.1111/his.14222. Epub 2020 Sep 15.
2
Bile duct adenoma and small-sized small duct type intrahepatic cholangiocarcinoma show distinct differences in genetic alterations, expression of IMP3 and EZH2 and stromal and inflammatory components.胆管腺瘤和小胆管型肝内胆管癌在遗传改变、IMP3 和 EZH2 的表达、基质和炎症成分方面存在明显差异。
Histopathology. 2023 Aug;83(2):298-309. doi: 10.1111/his.14932. Epub 2023 May 4.
3
Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.免疫组化染色多梳蛋白组蛋白 EZH2 和衰老标志物 p16INK4a 可能有助于鉴别胆毛细胆管细胞癌与胆管反应和胆管腺瘤。
Am J Surg Pathol. 2014 Mar;38(3):364-9. doi: 10.1097/PAS.0000000000000125.
4
Nestin may be a candidate marker for differential diagnosis between small duct type and large duct type intrahepatic cholangiocarcinomas.巢蛋白可能是鉴别小胆管型和大胆管型肝内胆管细胞癌的候选标志物。
Pathol Res Pract. 2024 Jan;253:155061. doi: 10.1016/j.prp.2023.155061. Epub 2023 Dec 22.
5
Expression of fibroblast growth factor receptor 2 (FGFR2) in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma: clinicopathological study.成纤维细胞生长因子受体 2(FGFR2)在肝细胞癌-胆管细胞癌联合癌和肝内胆管癌中的表达:临床病理研究。
Virchows Arch. 2024 Jun;484(6):915-923. doi: 10.1007/s00428-024-03792-x. Epub 2024 Mar 27.
6
Is nestin a diagnostic marker for combined hepatocellular-cholangiocarcinoma?巢蛋白是否可作为肝细胞胆管细胞癌的诊断标志物?
Histopathology. 2022 Apr;80(5):859-868. doi: 10.1111/his.14622. Epub 2022 Mar 3.
7
Diversity in cell differentiation, histology, phenotype and vasculature of mass-forming intrahepatic cholangiocarcinomas.肝内肿块型胆管细胞癌在细胞分化、组织学、表型和脉管系统方面的多样性。
Histopathology. 2021 Nov;79(5):731-750. doi: 10.1111/his.14417. Epub 2021 Aug 6.
8
Primary liver carcinoma in genetic hemochromatosis reveals a broad histologic spectrum.遗传性血色素沉着症中的原发性肝癌呈现出广泛的组织学谱。
Am J Clin Pathol. 2001 Nov;116(5):738-43. doi: 10.1309/2RFK-HD06-A788-1FJH.
9
Pathological aspects of mucinous cholangiocarcinoma: A single-center experience and systematic review.黏液型胆管细胞癌的病理学特征:单中心经验与系统综述。
Pathol Int. 2020 Sep;70(9):661-670. doi: 10.1111/pin.12983. Epub 2020 Jul 7.
10
Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.美国肝内胆管细胞癌与肝细胞癌的临床特征和结局比较。
Hepatology. 2021 Nov;74(5):2622-2632. doi: 10.1002/hep.32007. Epub 2021 Sep 25.

引用本文的文献

1
Magnetic resonance imaging features of intrahepatic bile duct adenoma: a 10-year retrospective study.肝内胆管腺瘤的磁共振成像特征:一项10年回顾性研究
BMC Med Imaging. 2025 May 26;25(1):188. doi: 10.1186/s12880-025-01733-x.
2
Multiple bile duct adenomas mimicking hepatic metastases during laparoscopic cholecystectomy - A case report.腹腔镜胆囊切除术期间多个酷似肝转移瘤的胆管腺瘤——病例报告
Int J Surg Case Rep. 2025 Mar;128:111082. doi: 10.1016/j.ijscr.2025.111082. Epub 2025 Feb 21.
3
Hepatic Biliary Adenofibroma: Histological Characteristics, Diagnostic Challenges, and Its Role as a Precursor to Intrahepatic Cholangiocarcinoma.
肝内胆管腺纤维瘤:组织学特征、诊断挑战及其作为肝内胆管癌前体的作用
J Clin Transl Pathol. 2024 Oct-Dec;4(4):163-167. doi: 10.14218/jctp.2024.00044. Epub 2024 Dec 24.
4
A Case of Resectable Single-Nodule Intrahepatic Bile Duct Adenoma.一例可切除的单结节肝内胆管腺瘤病例。
Cureus. 2024 Oct 16;16(10):e71656. doi: 10.7759/cureus.71656. eCollection 2024 Oct.
5
Cholangioscopy-assisted electrocoagulation therapy with electroacupuncture device for intraductal superficial lesions or hemobilia in porcine model.在猪模型中,使用电针装置进行胆道镜辅助电凝治疗导管内浅表病变或胆道出血。
Endosc Int Open. 2024 Jun 20;12(6):E767-E768. doi: 10.1055/a-2314-2891. eCollection 2024 Jun.
6
Editorial: Role of imaging in biliary tract cancer: diagnosis, staging, response prediction and image-guided therapeutics.社论:影像学在胆管癌中的作用:诊断、分期、疗效预测及影像引导治疗
Front Oncol. 2024 Mar 19;14:1387531. doi: 10.3389/fonc.2024.1387531. eCollection 2024.
7
Expert Consensus on Pathological Diagnosis of Intrahepatic Cholangiocarcinoma (2022 version).肝内胆管癌病理诊断专家共识(2022年版)
J Clin Transl Hepatol. 2023 Dec 28;11(7):1553-1564. doi: 10.14218/JCTH.2023.00118. Epub 2023 Jul 24.
8
Magnetic Resonance Imaging Findings of an Intrahepatic Bile Duct Adenoma: A Case Report.肝内胆管腺瘤的磁共振成像表现:一例报告
Cureus. 2022 Jul 20;14(7):e27082. doi: 10.7759/cureus.27082. eCollection 2022 Jul.
9
Variations in Cholangiocarcinoma: Clinical Significances and Molecular Mechanisms.胆管癌的变异:临床意义与分子机制
Front Oncol. 2021 Jun 25;11:693295. doi: 10.3389/fonc.2021.693295. eCollection 2021.